Intermediates

Bis(2,2,2-trifluoroethyl) carbonate

  • CAS No.1513-87-7
  • GradeIndustrial / Pharmaceutical
  • Availability● In Stock

High-Purity Bis(2,2,2-trifluoroethyl) Carbonate (CAS: 1513-87-7) is a key intermediate or starting material for advanced pharmaceutical synthesis. We offer proven large-scale production and delivery capabilities, along with custom contract manufacturing services.

Request Bulk Pricing

Product Technical Details

Basic Chemical Information & Core Applications

This product is also known as Pharmaceutical Grade TFEC, Advanced Fluorinated Carbonate Reagent, and Green Phosgene Alternative. Chemically, the introduction of a strong electron-withdrawing trifluoromethyl group into the molecular backbone endows the central carbonate group with high reactivity and excellent leaving group ability. In high-end pharmaceutical supply chains, this product is precisely positioned as a high-activity, eco-friendly condensation building block. It serves as a key precursor reagent for synthesizing asymmetric aliphatic urea-based targeted drugs (such as specific kinase inhibitors and antipsychotics) and tetrazole-derived APIs. Its main reaction byproduct system is extremely clean and easy to separate, specifically designed to replace the highly toxic phosgene or isocyanate reagent systems used in traditional pharmaceutical synthesis.

Product Specifications

Test ItemSpecification Parameter
Assay>= 98.0% (GC)
AppearanceColorless transparent liquid, no visually visible suspended particles

Process Design Philosophy & Quality Advantages

Addressing QA audit concerns associated with traditional commercial fluorinated reagents—such as thermal degradation during prolonged batch heating causing yellowing, and excessive free acid due to incomplete neutralization quenching—we have implemented a fundamental process route reconstruction. Production relies on engineering concepts of extremely short thermal history control and microchannel instantaneous quenching, combined with system-level deep pressure differential solvent removal and strict pre-physical isolation technology. This effectively intervenes in reaction equilibrium and completely cuts off the reverse degradation pathways for salts and impurities. This process design aims to meet near-stringent color and low free acid control standards. The expected advantage is to significantly reduce or eliminate cumbersome decolorization and purification steps for downstream advanced CDMOs or originator pharmaceutical companies, avoiding compliance risks associated with the introduction of highly toxic reagents and heavy metals from the source, thereby providing highly pure fine chemical synthesis building blocks with excellent batch consistency.

Source Factory & Proprietary Continuous Flow Technology Advantages

Ningbo Yino Chemicals Co., Ltd., as the source manufacturer, possesses self-developed and self-designed inline continuous flow reaction equipment. Relying on excellent batch stability and an inherently safe production system, we ensure consistent quality for every delivery batch. We sincerely look forward to establishing long-term strategic partnerships with trading companies and end-users to jointly develop the high-end fluorinated intermediate market.